心电测量法用于儿童脓毒性休克管理:一项先导性随机对照试验
这项在三级医院PICU开展的单中心随机对照试验纳入119例2个月至18岁、初始液体负荷后休克未缓解的脓毒性休克患儿,比较心电测量法联合临床监测指导液体复苏及血管活性药物选择与滴定(B组,59例)与单纯临床监测(A组,60例)的差异。结果显示A组最初6小时复苏液量显著更高(30±8.2 vs 22±9.2 mL/kg),最初24小时维持加复苏液总量也更高(56±13 vs 46±10.7,p<0.001),B组血管活性治疗启动更早(37±10.14 vs 47.33±12.41 min)、液体过负荷百分比更低(2.98% vs 1.7%)。但休克缓解时间、28天无ICU天数、无住院天数及病死率均无差异。作者认为,心电测量法联合临床评估可实现限制性液体策略并降低液体过负荷风险。
要点
- 初始液体负荷后休克未缓解的2个月至18岁脓毒性休克患儿,加用心电测量法监测(B组)最初6小时复苏液量为22±9.2 mL/kg,低于单纯临床监测(A组)的30±8.2 mL/kg。
- B组最初24小时维持加复苏液总量为46±10.7 mL/kg,低于A组的56±13 mL/kg(p<0.001)。
- B组启动血管活性治疗更早(37±10.14 vs 47.33±12.41 min),液体过负荷百分比更低(2.98% vs 1.7%)。
- 两组休克缓解时间、28天无ICU天数、无住院天数及病死率无差异。
- 作者认为心电测量法联合临床评估可实现限制性液体策略并降低液体过负荷风险。
适用人群与场景
- 2个月至18岁脓毒性休克患儿,且初始液体负荷后休克未缓解。
- PICU住院患儿。
处置流程与药物剂量
- B组(心电测量法联合临床监测组):依据心电测量法变量(心脏指数和体循环血管阻力指数)联合临床监测指导液体负荷,以及血管活性药物的选择与滴定。
- A组(单纯临床监测组):按标准指南使用临床参数启动和滴定液体复苏及血管活性治疗。
研究设计与关键结果
- 单中心随机对照试验,纳入119例患儿(A组60例,B组59例)。
- 最初6小时复苏液量(均值±标准差):A组30±8.2 mL/kg,B组22±9.2 mL/kg。
- 最初24小时维持加复苏液总量(均值±标准差):A组56±13 mL/kg,B组46±10.7 mL/kg(p<0.001)。
- 血管活性治疗启动时间:B组37±10.14 min,A组47.33±12.41 min;液体过负荷百分比:B组2.98%,A组1.7%。
- 休克缓解时间、28天无ICU天数、无住院天数及病死率两组无差异。
证据类型、等级与局限
- 证据类型:单中心先导性随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在临床评估基础上加用心电测量法进行高级血流动力学监测,可实现限制性液体策略并降低液体过负荷风险。
- 该先导性研究未显示休克缓解时间、28天无ICU天数、无住院天数及病死率获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the difference in the resuscitation fluid volume in the initial 6 hours in pediatric septic shock between those undergoing noninvasive continuous hemodynamic monitoring with electrocardiometry in addition to clinical monitoring vs. clinical monitoring alone.
DESIGN: Randomized control trial.
SETTING: PICU in a tertiary care hospital.
PATIENTS: Children from 2 months to 18 years with sepsis and unresolved shock after the initial fluid bolus (FB).
INTERVENTIONS: Children were randomized to one of the two groups, that is, electrocardiometry with clinical monitoring group (group B) and clinical monitoring alone group (group A). In group B, electrocardiometry variables (cardiac index and systemic vascular resistance index) along with clinical monitoring were used to guide FB, as well as selection and titration of vasoactive agents. Clinical parameters were used to initiate and titrate fluid resuscitation and vasoactive therapy in group A as per standard guidelines.
MEASUREMENTS AND MAIN RESULTS: One hundred nineteen children were enrolled in the study: 60 in group A and 59 in group B. There was a significantly higher requirement for resuscitation fluid volume (mean ± sd) within the initial 6 hours in the group A (30 ± 8.2 mL/kg) as compared with group B (22 ± 9.2 mL/kg). Similarly, maintenance along with resuscitation fluid volume (mean ± sd) administration (56 ±13 vs. 46 ±10.7, p < 0.001) was higher in group A in the first 24 hours of enrollment. Vasoactive therapy initiation was earlier in group B as compared with group A (37 ± 10.14 vs. 47.33 ± 12.41 min) with lower fluid overload percentage (2.98% vs. 1.7%) in this group. However, there was no difference in time to shock resolution, 28-day ICU-free days, hospital-free days, and mortality.
CONCLUSIONS: Advanced hemodynamic monitoring with electrocardiometry along with clinical assessment led to a restrictive fluid strategy in addition to minimizing the risk of fluid overload.
参考来源
- Moharana SS, Av L, Ghosh S, et al. Electrocardiometry for the Management of Pediatric Septic Shock: A Pilot Randomized Controlled Trial. Crit Care Explor. 2025. PMID: 40162863. doi:10.1097/CCE.0000000000001242
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。